Vimarsana
Biggest News Aggregation in the World

Page 4 - Takeover Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Takeover Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Takeover Act Today - Breaking & Trending Today

Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisition of around 59% of the shares in KATEK SE -February 28, 2024 at 06:02 am EST - Vimarsana News

Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisition of around 59% of the shares in KATEK SE -February 28, 2024 at 06:02 am EST

EQS-Ad-hoc: Kontron AG / Key word: Mergers & Acquisitions Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisition of around 59% of the shares in KATEK SE 28-Feb-2024 /...

EQS-Adhoc: Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisition of around 59% of the shares in KATEK SE - Vimarsana News

EQS-Adhoc: Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisition of around 59% of the shares in KATEK SE

EQS-Ad-hoc: Kontron AG / Key word(s): Mergers & Acquisitions Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisit...

EQS-News: Südzucker AG successfully completes delisting tender offer - Vimarsana News

EQS-News: Südzucker AG successfully completes delisting tender offer

EQS-News: Südzucker AG / Key word(s): Tender Offer Südzucker AG successfully completes delisting tender offer ...

MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value - Vimarsana News

MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value

Tafasitamab sold to IncyteNovartis to launch a voluntary public takeover offer for all MorphoSys shares at a price of € 68.00 per share in cashShareholders benefit from attractive premium of 94 percent to the one-month volume weighted average price before January 25, 2024Novartis provides ample resources to maximize...

MorphoSys Enters into Business Combination Agreement to be acquired by Novartis for EUR 2.7 Billion Equity Value - Vimarsana News

MorphoSys Enters into Business Combination Agreement to be acquired by Novartis for EUR 2.7 Billion Equity Value

Germany - MorphoSys AG today announced the company entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG based on Novartis' intention to submit a voluntary public...